Published in Women's Health Weekly, October 2nd, 2008
"Experimental During the first, second and ninth cycle of treatment, blood, urine and CAPD samples were collected for pharmacokinetic analysis of paclitaxel and total and unbound carboplatin-derived platinum. Treatment was well tolerated by the patient. No excessive toxicity was observed and at the end of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly